Report: Advances in Biopharmaceutical Technology in China from Piribo.com

Abstracts
Chapter 1: Introduction: A China Biopharmaceuticals Strategy
Chapter 2: An Overview of Biopharmaceutical Developments in China
Chapter 3: China's Healthcare System and the Demand for Biopharmaceutical Products
Chapter 4: China Pharmaceuticals Market Situation 2006
Chapter 5: Biopharmaceutical Strategy in China: An Analysis of Innovation, Financing Policies, Talent, and Strategic Considerations Through 2010 (11th 5-year Plan)
Chapter 6: Biopharmaceuticals in China: A Market, Import/Export, and Financial Review
Chapter 7: Pharmacy and Drug Administration in China
Chapter 8: Regulatory Requirements Applicable to Clinical Trials in China
Chapter 9: FDA Requirements Applicable to Testing and Manufacturing Pharmaceutical Products in China for the U. S. Market
Chapter 10: Protection and Enforcement of Biopharmaceutical Intellectual Property Rights in China - A Rapidly Evolving System
Chapter 11: Biopharmaceutical Industry Venture Capital Investment in Mainland China
Chapter 12: Drug Discovery and Development Partnerships: Outsourcing and Partnering with China
Chapter 13: Doing Business in China
Chapter 14: Current Status and Future Prospect of Biogeneric Companies in China
Chapter 15: Biopharmaceutical Products in China
Chapter 16: Chinese Bioindustry Parks: Evolution and Growth
Chapter 17: Organizations in China involved in Biopharmaceutical Research and Manufacturing
Chapter 18: Life Science and Health Science Education in China
Chapter 19: Biopharmaceutical Research Collaboration between Western and Chinese Life Science Organization: A Guide to Prospective Partnership
Chapter 20: Industrial Technology Developments for Chinese Biopharmaceuticals
Chapter 21: Therapeutic Proteins in China
Chapter 22: Vaccines in China: Status of the Chinese Vaccine Industry
Chapter 23: Biotechnology and Analytical Methods in the Modernization of Traditional Chinese Herbal Medicine
Chapter 24: CHINA Briefs (Miscellaneous Articles)
Author Organizations:
- Arnold & Porter, LLP
- Beijing BaiAo Pharmaceutical Co., Ltd.
- Beijing WanTai Biological Product Co., Ltd.
- Business Monitor International
- CanBiotech
- Chemical Industry Press (China)
- Chiltern International
- China National Center for Biotechnology Development
- China National Development and Reform Commission, Chinese Academy of Macroeconomic Research
- China National Development and Reform Commission, High-Tech Industry Department
- China Pharmaceutical University, College of Life Science and Technology
- Chinese Academy of Social Sciences (CASS), Institute of World Economics and Politics
- Chinese Ministry of Science and Technology, National Advisory Committee for "863 High Technology Program"
- Deacons Hong Kong
- Fudan University, International Finance
- MMD Pharmahe
- Nanjing University, Department of Biochemistry
- National Institutes of Health (NIH), Office of Technology Transfer
- National Vaccine & Serum Institute
- Perkins Coie LLP (Los Angeles)
- Shandong University
- Shanghai CITIC GuoJian Pharmaceutical Co., Ltd.
- Shanghai Tongji University, Investment Research Institute
- Shanghai Venture Capital Corporation
- Shenzhen Neptunus Interlong Biotech Co., Ltd
- Shenzhen ZYPH Intelligence Co., Ltd.
- Sichuan University, West China School of Pharmacy
- Strategic Manufacturing Worldwide, Inc.
- TechNova Medical Services
- Tsinghua University, School of Medicine
- 3DBGlobal, Inc.

Technologies

Advances in Biopharmaceutical Technology in China

Price £3,410.00

Summary

Purchasing the PDF version of this product you are recieving a global user license

Content

Bookmark this Product